Literature DB >> 31152300

Type II diabetes mellitus and the incidence of amyotrophic lateral sclerosis.

Ching-Piao Tsai1,2, Johnny Kuang-Wu Lee3, Charles Tzu-Chi Lee4.   

Abstract

OBJECTIVE: The aim of this study was to investigate the relationship between type II diabetes mellitus (T2DM) and ALS incidence using the National Health Insurance Research Database and Serious Disabling Disease database of Taiwan.
METHODS: This was a population-based cohort study. The index date was the date of the first T2DM diagnosis + 365 days. We included T2DM patients diagnosis between 2000 and 2013 (n = 2,135,427). These patients were matched by sex, age, urbanization, and insurance premium at a ratio of 1:1 to include patients without diabetes mellitus. Competing risk-adjusted Cox regression analysis was performed to investigate the association between T2DM and the incidence of ALS.
RESULTS: In the patients not stratified by age, T2DM was not associated with the incidence of ALS after controlling for confounding factors. The interaction test of age subgroup (< 55 and ≥ 55 years) and T2DM on ALS risk was significance (p < 0.001). Subgroup analysis showed that T2DM was negatively associated with ALS in patients whose age at the first T2DM diagnosis was ≥ 55 years. Among T2DM patients, T2DM combined with hypertension was negatively associated with ALS among patients whose age at the first T2DM diagnosis was ≥ 55 years. Among T2DM patients, T2DM combined with hyperlipidemia was positively associated with ALS among patients whose age at the first T2DM diagnosis was < 55 years.
CONCLUSIONS: The late-onset of T2DM may exert negative association with ALS, especially when combined with hypertension. The early-onset of T2DM may exert positive association with ALS, especially when combined with hyperlipidemia.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Cohort study; Diabetes mellitus; National Health Insurance Database; Serious Disabling Disease Database

Mesh:

Year:  2019        PMID: 31152300     DOI: 10.1007/s00415-019-09405-x

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  7 in total

Review 1.  Adenosine deaminase, not immune to a mechanistic rethink in central nervous system disorders?

Authors:  Benjamin Hall; Jonathan G George; Scott P Allen
Journal:  Histol Histopathol       Date:  2021-12-09       Impact factor: 2.303

2.  Association of Hemoglobin A1C With TDP-43 Pathology in Community-Based Elders.

Authors:  Shahram Oveisgharan; Ana W Capuano; Sukriti Nag; Sonal Agrawal; Lisa L Barnes; David A Bennett; Zoe Arvanitakis; Julie A Schneider
Journal:  Neurology       Date:  2021-04-14       Impact factor: 11.800

Review 3.  The links between diabetes mellitus and amyotrophic lateral sclerosis.

Authors:  Rosario Vasta; Fabrizio D'Ovidio; Giancarlo Logroscino; Adriano Chiò
Journal:  Neurol Sci       Date:  2021-02-05       Impact factor: 3.307

4.  The GLP-1 receptor agonist, liraglutide, fails to slow disease progression in SOD1G93A and TDP-43Q331K transgenic mouse models of ALS.

Authors:  Amy Keerie; Heledd Brown-Wright; Isaac Kirkland; Andrew Grierson; James J P Alix; Christian Holscher; Richard J Mead
Journal:  Sci Rep       Date:  2021-08-23       Impact factor: 4.379

5.  Pre-Morbid Risk Factors for Amyotrophic Lateral Sclerosis: Prospective Cohort Study.

Authors:  G David Batty; Catharine R Gale
Journal:  Clin Epidemiol       Date:  2021-10-07       Impact factor: 4.790

6.  Association between type 2 diabetes and amyotrophic lateral sclerosis.

Authors:  Tao Huang; Dongsheng Fan; Linjing Zhang; Lu Tang
Journal:  Sci Rep       Date:  2022-02-15       Impact factor: 4.379

Review 7.  Amyotrophic Lateral Sclerosis: A Diet Review.

Authors:  Salvatore D'Antona; Martina Caramenti; Danilo Porro; Isabella Castiglioni; Claudia Cava
Journal:  Foods       Date:  2021-12-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.